Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

6(86%)

Results Posted

100%(1 trials)

Phase Distribution

Ph phase_2

29%

Ph not_applicable

43%

Ph phase_1

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

1(16.7%)

Phase 2Efficacy & side effects

2(33.3%)

N/ANon-phased studies

3(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(6)

Completed(1)

Detailed Status

Recruiting4

Active, not recruiting2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (16.7%)

Phase 22 (33.3%)

N/A3 (50.0%)

Trials by Status

recruiting457%

active_not_recruiting229%

completed114%

Recent Activity

6 active trials

Showing 5 of 7

recruitingphase_2

A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease

NCT04590508

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT06225258Phase 2

Xanthohumol as an Adjuvant in the Treatment of Septic Shock

Recruiting

NCT06745102Not Applicable

Hop Compounds on the Immune System in Overweight People

Recruiting

NCT06286657Not Applicable

Xanthohumol and Viral Infections (XL)

Recruiting

NCT06286644Not Applicable

Hop Compounds on the Immune System (VH)

Recruiting

NCT04590508Phase 2

A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease

Active Not Recruiting

NCT03735420Phase 1

Xanthohumol Metabolism and Signature

Active Not Recruiting

NCT01367431

Xanthohumol and Metabolic Syndrome

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7